Security Snapshot

AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share (AIMI) Institutional Ownership

CUSIP: 00901B105

13F Institutional Holders and Ownership History from Q3 2019 to Q2 2025

Latest Period

n/a

Institutions Reporting

Shares (Excl. Options)

Price

$0.07

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Shares outstanding
18,121,202
SEC-reported price per share
$0.07
Insider filing price
$0.07
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • AIMI - AIM ImmunoTech Inc. - Common Stock, par value $0.001 per share is tracked under CUSIP 00901B105.
  • Latest finished 13F holder period is not available.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 32 to 0 between Q1 2025 and Q2 2025.
  • SEC-reported value moved from $590,031 to $0.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Schedule 13D/G

Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.

Open SEC evidence

Security key

00901B105

Latest holder period

n/a

13F holders

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
AIMI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 5% $200,984 3,349,740 Armistice Capital, LLC 31 Dec 2024
Orca Capital AG 9.9% $125,580 1,793,999 Orca Capital AG 07 May 2026
Deutsch Todd 2.7% $102,966 1,716,100 Todd Deutsch 19 Dec 2024

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
24
Latest
n/a
Rows shown
1-24 of 24
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q2 0 $0 -$590,031 $0.07 0
2025 Q1 4,830,582 $590,031 +$13,162 $0.12 32
2024 Q4 4,647,474 $919,320 -$1,176,683 $0.20 34
2024 Q3 9,012,614 $2,433,450 +$137,613 $0.27 31
2024 Q2 8,443,754 $3,147,046 +$1,617,267 $0.37 32
2024 Q1 4,093,657 $1,928,158 -$25,009 $0.47 29
2023 Q4 4,153,302 $1,827,252 -$76,071 $0.44 34
2023 Q3 4,325,469 $1,967,698 -$88,008 $0.46 33
2023 Q2 4,487,861 $3,007,274 -$158,270 $0.67 30
2023 Q1 4,759,372 $2,047,309 -$250,545 $0.43 31
2022 Q4 5,359,615 $1,671,272 -$139,037 $0.31 34
2022 Q3 5,772,330 $3,360,006 -$143,308 $0.58 27
2022 Q2 6,001,972 $4,680,348 -$590,475 $0.78 29
2022 Q1 6,715,161 $7,116,832 -$763,828 $1.06 30
2021 Q4 7,461,218 $6,859,970 +$35,541 $0.92 36
2021 Q3 7,299,789 $14,742,461 +$161,035 $2.02 35
2021 Q2 7,205,272 $15,488,490 -$493,510 $2.15 34
2021 Q1 7,420,355 $16,843,868 +$9,793,564 $2.27 32
2020 Q4 3,129,359 $5,599,408 +$598,092 $1.79 29
2020 Q3 2,752,198 $5,919,890 +$1,860,731 $2.15 30
2020 Q2 1,872,603 $4,644,565 +$3,210,986 $2.48 20
2020 Q1 566,168 $1,449,584 +$1,054,741 $2.56 18
2019 Q4 564,017 $307,124 -$619,201 $0.54 6
2019 Q3 1,271,953 $970,174 +$970,174 $0.76 8
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .